June 22, 2020
Vicore Pharma’s drug candidate VP01 demonstrates potential for significant benefit in severe pulmonary hypertension
Media
June 22, 2020
Targovax to present at the upcoming 2020 Virtual European Biotech Investor Day 2020
June 22, 2020
Targovax’s ONCOS-102 mesothelioma 12-month data powerfully demonstrate broad immune activation linked to clinical benefit
June 18, 2020
Orexo – in Wired Magazine
June 17, 2020
Orexo and Lyfebulb Announce Call for Digital Solutions to Treat Substance Use Disorder
June 15, 2020
BONESUPPORT FORTIFY PATIENT ENROLLEMENT FINALIZED EARLIER THAN ORIGINAL PLAN
June 15, 2020
Oncopeptides reports positive results from full data set of Phase 2 HORIZON trial in triple-class refractory multiple myeloma patients
June 12, 2020
Aprea Therapeutics Presents Results From French Phase Ib/II Clinical Trial of APR-246 (Eprenetapopt) and Azacitidine in Patients with TP53 Mutant Myelodysplastic Syndromes and Acute Myeloid Leukemia at the 25th European Hematology Association Annual Meeting
June 11, 2020
Oncopeptides hosts a virtual symposium at the 25th European Hematology Association Congress on Challenges in Managing Patients with Myeloma
June 10, 2020
Doctrin appoints Anna-Karin Edstedt Bonamy as new CEO